> top > docs > PMC:7161517 > spans > 468-772 > annotations

PMC:7161517 / 468-772 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T6 209-222 Disease denotes viral disease http://purl.obolibrary.org/obo/MONDO_0005108
T7 281-303 Disease denotes cardiovascular disease http://purl.obolibrary.org/obo/MONDO_0004995

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T3 139-142 http://purl.obolibrary.org/obo/CLO_0051582 denotes has

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T4 8-22 Chemical denotes angiotensin II http://purl.obolibrary.org/obo/CHEBI_2719|http://purl.obolibrary.org/obo/CHEBI_48432|http://purl.obolibrary.org/obo/CHEBI_58506
T7 8-19 Chemical denotes angiotensin http://purl.obolibrary.org/obo/CHEBI_48433
T8 20-22 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067
T9 42-56 Chemical denotes ACE inhibitors http://purl.obolibrary.org/obo/CHEBI_35457
T10 46-56 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T11 62-79 Chemical denotes mineralocorticoid http://purl.obolibrary.org/obo/CHEBI_25354
T12 89-100 Chemical denotes antagonists http://purl.obolibrary.org/obo/CHEBI_48706

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T6 0-304 Sentence denotes Because angiotensin II receptor blockers, ACE inhibitors, and mineralocorticoid receptor antagonists increase ACE2 receptor expression, it has been tacitly believed that the use of these agents may facilitate viral disease; thus, they should not be used in high-risk patients with cardiovascular disease.

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 281-303 Phenotype denotes cardiovascular disease http://purl.obolibrary.org/obo/HP_0001626

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T15 8-22 DG_37;PR:000001118 denotes angiotensin II
T16 23-31 PR:000001118 denotes receptor
T17 46-56 CHEBI:35222;CHEBI:35222 denotes inhibitors
T18 62-79 CHEBI:25354;CHEBI:25354 denotes mineralocorticoid
T19 80-100 CHEBI:48561;CHEBI:48561 denotes receptor antagonists
T20 110-114 PR:000003622;G_3;PG_10 denotes ACE2
T21 124-134 GO:0010467 denotes expression
T22 187-193 CHEBI:48561;CHEBI:48561 denotes agents
T23 209-214 NCBITaxon:10239 denotes viral
T24 281-295 UBERON:0004535 denotes cardiovascular
T39187 8-22 DG_37;PR:000001118 denotes angiotensin II
T33501 23-31 PR:000001118 denotes receptor
T28542 46-56 CHEBI:35222;CHEBI:35222 denotes inhibitors
T14634 62-79 CHEBI:25354;CHEBI:25354 denotes mineralocorticoid
T38268 80-100 CHEBI:48561;CHEBI:48561 denotes receptor antagonists
T7996 110-114 PR:000003622;G_3;PG_10 denotes ACE2
T85494 124-134 GO:0010467 denotes expression
T23807 187-193 CHEBI:48561;CHEBI:48561 denotes agents
T85043 209-214 NCBITaxon:10239 denotes viral
T68089 281-295 UBERON:0004535 denotes cardiovascular

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
26 42-45 Gene denotes ACE Gene:1636
27 62-88 Gene denotes mineralocorticoid receptor Gene:4306
28 110-114 Gene denotes ACE2 Gene:59272
34 267-275 Species denotes patients Tax:9606
37 209-222 Disease denotes viral disease MESH:D001102
38 281-303 Disease denotes cardiovascular disease MESH:D002318